secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0000950170-23-030542
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics stockholders elect three Class II directors and ratify KPMG as auditor at annual meeting
--------------------------------------------------------------------------------

- Elected Edward J. Benz Jr., Paul B. Manning, and Paul Peter Tak as Class II directors; each received over 10.7M votes for.
- Ratified KPMG as independent auditor for FY2023 with 15,388,012 for, 82,122 against, 1,081 abstain.
- Broker non-votes on director election totaled 4,502,642 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000095017023030542/0000950170-23-030542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000095017023030542/cadl-20230628.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-030542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer